PMC:7195088 / 34467-34650
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1022 | 77-85 | Species | denotes | patients | Tax:9606 |
| 1023 | 141-152 | Chemical | denotes | ruxolitinib | MESH:C540383 |
| 1024 | 154-165 | Chemical | denotes | baricitinib | MESH:C000596027 |
| 1025 | 170-181 | Chemical | denotes | tofacitinib | MESH:C479163 |
| 1027 | 91-99 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T177 | 91-99 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T470 | 49-54 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T471 | 130-140 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T472 | 141-152 | Chemical | denotes | ruxolitinib | http://purl.obolibrary.org/obo/CHEBI_66919 |
| T473 | 170-181 | Chemical | denotes | tofacitinib | http://purl.obolibrary.org/obo/CHEBI_71200 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T278 | 0-183 | Sentence | denotes | Of note, there are also registered RCT for other drugs to be investigated in patients with COVID-19 (e.g. the Janus kinase family inhibitors ruxolitinib, baricitinib and tofacitinib). |